Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 372

1.

Dynamics of genomic, epigenomic, and transcriptomic aberrations during stepwise hepatocarcinogenesis.

Jee BA, Choi JH, Rhee H, Yoon S, Kwon SM, Nahm JH, Yoo JE, Jeon Y, Choi GH, Woo HG, Park YN.

Cancer Res. 2019 Sep 10. pii: canres.0991.2019. doi: 10.1158/0008-5472.CAN-19-0991. [Epub ahead of print]

PMID:
31506333
2.

CRISPR knockout screen implicates three genes in lysosome function.

Lenk GM, Park YN, Lemons R, Flynn E, Plank M, Frei CM, Davis MJ, Gregorka B, Swanson JA, Meisler MH, Kitzman JO.

Sci Rep. 2019 Jul 3;9(1):9609. doi: 10.1038/s41598-019-45939-w.

3.

Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection.

Kim HS, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Park YN, Han DH, Kim KS, Choi JS, Choi GH, Kim HS.

Clin Mol Hepatol. 2019 Jun 27. doi: 10.3350/cmh.2018.0073. [Epub ahead of print]

4.

Reciprocal signaling and direct physical interactions between fibroblasts and breast cancer cells in a 3D environment.

Wessels DJ, Pradhan N, Park YN, Klepitsch MA, Lusche DF, Daniels KJ, Conway KD, Voss ER, Hegde SV, Conway TP, Soll DR.

PLoS One. 2019 Jun 24;14(6):e0218854. doi: 10.1371/journal.pone.0218854. eCollection 2019.

5.

Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma.

Renne SL, Woo HY, Allegra S, Rudini N, Yano H, Donadon M, Viganò L, Akiba J, Lee HS, Rhee H, Park YN, Roncalli M, Di Tommaso L.

Hepatology. 2019 Jun 17. doi: 10.1002/hep.30814. [Epub ahead of print]

PMID:
31206715
6.

Optimal lexicon of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of hepatocellular carcinoma modified from LI-RADS.

Hwang SH, Park S, Han K, Choi JY, Park YN, Park MS.

Abdom Radiol (NY). 2019 Sep;44(9):3078-3088. doi: 10.1007/s00261-019-02077-1.

PMID:
31165907
7.

Roles of the Transcription Factors Sfl2 and Efg1 in White-Opaque Switching in a/α Strains of Candida albicans.

Park YN, Conway K, Conway TP, Daniels KJ, Soll DR.

mSphere. 2019 Apr 17;4(2). pii: e00703-18. doi: 10.1128/mSphere.00703-18.

8.

Hepatocellular Carcinoma with Irregular Rim-Like Arterial Phase Hyperenhancement: More Aggressive Pathologic Features.

Rhee H, An C, Kim HY, Yoo JE, Park YN, Kim MJ.

Liver Cancer. 2019 Feb;8(1):24-40. doi: 10.1159/000488540. Epub 2018 May 15.

9.

Orally administration of Neolentinus lepideus extracts attenuated ethanol induced accumulation of hepatic lipid in mice.

Park KM, Park YN, Kwon OY, Lee SH.

Food Sci Biotechnol. 2018 Aug 14;28(1):243-251. doi: 10.1007/s10068-018-0451-9. eCollection 2019 Feb.

10.

Do Emotional Laborers Help the Needy More or Less? The Mediating Role of Sympathy in the Effect of Emotional Dissonance on Prosocial Behavior.

Park YN, Hyun H, Jhang J.

Front Psychol. 2019 Feb 7;10:118. doi: 10.3389/fpsyg.2019.00118. eCollection 2019.

11.

WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation.

Jeong WJ, Park JC, Kim WS, Ro EJ, Jeon SH, Lee SK, Park YN, Min DS, Choi KY.

Nat Commun. 2019 Jan 17;10(1):295. doi: 10.1038/s41467-018-08230-6.

12.

A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.

Rhee H, Kim MJ, Park YN, An C.

Eur Radiol. 2019 Jun;29(6):3111-3121. doi: 10.1007/s00330-018-5898-9. Epub 2018 Dec 17.

PMID:
30560357
13.

Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI.

Lee S, Kim MJ, Kim S, Choi D, Jang KT, Park YN.

J Hepatol. 2019 Apr;70(4):692-699. doi: 10.1016/j.jhep.2018.12.005. Epub 2018 Dec 14.

PMID:
30553839
14.

Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival.

Kleinegger F, Hofer E, Wodlej C, Golob-Schwarzl N, Birkl-Toeglhofer AM, Stallinger A, Petzold J, Orlova A, Krassnig S, Reihs R, Niedrist T, Mangge H, Park YN, Thalhammer M, Aigelsreiter A, Lax S, Garbers C, Fickert P, Rose-John S, Moriggl R, Rinner B, Haybaeck J.

Biochim Biophys Acta Mol Basis Dis. 2019 Feb 1;1865(2):308-321. doi: 10.1016/j.bbadis.2018.11.006. Epub 2018 Nov 9.

15.

Identification of molecular signatures involved in radiation-induced lung fibrosis.

Jin H, Kang GY, Jeon S, Kim JM, Park YN, Cho J, Lee YS.

J Mol Med (Berl). 2019 Jan;97(1):37-47. doi: 10.1007/s00109-018-1715-9. Epub 2018 Nov 7.

16.

Suppression of PROX1-mediated TERT expression in hepatitis B viral hepatocellular carcinoma.

Kim YJ, Yoo JE, Jeon Y, Chong JU, Choi GH, Song DG, Jung SH, Oh BK, Park YN.

Int J Cancer. 2018 Dec 15;143(12):3155-3168. doi: 10.1002/ijc.31731. Epub 2018 Sep 27.

PMID:
29987895
17.

Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis.

Choi J, Chung T, Rhee H, Kim YJ, Jeon Y, Yoo JE, Noh S, Han DH, Park YN.

Gut Liver. 2019 Jan 15;13(1):83-92. doi: 10.5009/gnl17569.

18.

Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer.

Yoon S, Lee EJ, Choi JH, Chung T, Kim DY, Im JY, Bae MH, Kwon JH, Kim HH, Kim HC, Park YN, Wang HJ, Woo HG.

Oncogene. 2018 Aug;37(32):4443-4454. doi: 10.1038/s41388-018-0291-3. Epub 2018 May 3.

PMID:
29720727
19.

Candida albicans White-Opaque Switching Influences Virulence but Not Mating during Oropharyngeal Candidiasis.

Solis NV, Park YN, Swidergall M, Daniels KJ, Filler SG, Soll DR.

Infect Immun. 2018 May 22;86(6). pii: e00774-17. doi: 10.1128/IAI.00774-17. Print 2018 Jun.

20.

Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Burt AD, Alves V, Bedossa P, Clouston A, Guido M, Hübscher S, Kakar S, Ng I, Park YN, Reeves H, Wyatt J, Yeh MM, Ellis DW.

Histopathology. 2018 Sep;73(3):369-385. doi: 10.1111/his.13520. Epub 2018 May 30. Review.

PMID:
29573451
21.

Generating a Battery of Monoclonal Antibodies Against Firefly Luciferase for Dot Blot Analysis, Western Blot Analysis, and Immunostaining of Cells in Culture and Paraffin Sections.

Conway TP, Daniels KJ, Park YN, Soll DR.

Monoclon Antib Immunodiagn Immunother. 2018 Feb;37(1):45-51. doi: 10.1089/mab.2017.0057.

PMID:
29474160
22.

Liver fibrosis: stretched exponential model outperforms mono-exponential and bi-exponential models of diffusion-weighted MRI.

Seo N, Chung YE, Park YN, Kim E, Hwang J, Kim MJ.

Eur Radiol. 2018 Jul;28(7):2812-2822. doi: 10.1007/s00330-017-5292-z. Epub 2018 Feb 5.

PMID:
29404771
23.

Keratin 19 Expression in Hepatocellular Carcinoma Is Regulated by Fibroblast-Derived HGF via a MET-ERK1/2-AP1 and SP1 Axis.

Rhee H, Kim HY, Choi JH, Woo HG, Yoo JE, Nahm JH, Choi JS, Park YN.

Cancer Res. 2018 Apr 1;78(7):1619-1631. doi: 10.1158/0008-5472.CAN-17-0988. Epub 2018 Jan 23.

24.

Alpers-Huttenlocher Syndrome First Presented with Hepatic Failure: Can Liver Transplantation Be Considered as Treatment Option?

Park S, Kang HC, Lee JS, Park YN, Kim S, Koh H.

Pediatr Gastroenterol Hepatol Nutr. 2017 Dec;20(4):259-262. doi: 10.5223/pghn.2017.20.4.259. Epub 2017 Dec 22.

25.

Sensitization of lung cancer cells by altered dimerization of HSP27.

Choi B, Choi SK, Park YN, Kwak SY, Lee HJ, Kwon Y, Na Y, Lee YS.

Oncotarget. 2017 Oct 31;8(62):105372-105382. doi: 10.18632/oncotarget.22192. eCollection 2017 Dec 1.

26.

Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study.

Nahm JH, Rhee H, Kim H, Yoo JE, San Lee J, Jeon Y, Choi GH, Park YN.

Oncotarget. 2017 Oct 26;8(59):99359-99371. doi: 10.18632/oncotarget.22078. eCollection 2017 Nov 21.

27.

IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.

Kessler SM, Lederer E, Laggai S, Golob-Schwarzl N, Hosseini K, Petzold J, Schweiger C, Reihs R, Keil M, Hoffmann J, Mayr C, Kiesslich T, Pichler M, Kim KS, Rhee H, Park YN, Lax S, Obrist P, Kiemer AK, Haybaeck J.

Oncotarget. 2017 Sep 21;8(52):89736-89745. doi: 10.18632/oncotarget.21116. eCollection 2017 Oct 27.

28.

Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B.

Heo JY, Kim BK, Park JY, Kim DY, Ahn SH, Kim HS, Park YN, Han KH, Song K, Kim SU.

Gut Liver. 2018 Mar 15;12(2):190-200. doi: 10.5009/gnl17092.

29.

Dielectric imaging for differentiation between cancer and inflammation in vivo.

Lee R, Lee SM, Kim HJ, Kim SY, Son M, Song JH, Lkhamsuren K, Park IH, Choi IH, Park YN, Shin JS, Yoo KH.

Sci Rep. 2017 Oct 13;7(1):13137. doi: 10.1038/s41598-017-13545-3.

30.

Protocol for Identifying Natural Agents That Selectively Affect Adhesion, Thickness, Architecture, Cellular Phenotypes, Extracellular Matrix, and Human White Blood Cell Impenetrability of Candida albicans Biofilms.

Park YN, Srikantha T, Daniels KJ, Jacob MR, Agarwal AK, Li XC, Soll DR.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01319-17. doi: 10.1128/AAC.01319-17. Print 2017 Nov.

31.

Sirt1 negatively regulates FcεRI-mediated mast cell activation through AMPK- and PTP1B-dependent processes.

Li X, Lee YJ, Jin F, Park YN, Deng Y, Kang Y, Yang JH, Chang JH, Kim DY, Kim JA, Chang YC, Ko HJ, Kim CH, Murakami M, Chang HW.

Sci Rep. 2017 Jul 25;7(1):6444. doi: 10.1038/s41598-017-06835-3.

32.

New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors.

Golob-Schwarzl N, Krassnig S, Toeglhofer AM, Park YN, Gogg-Kamerer M, Vierlinger K, Schröder F, Rhee H, Schicho R, Fickert P, Haybaeck J.

Eur J Cancer. 2017 Sep;83:56-70. doi: 10.1016/j.ejca.2017.06.003. Epub 2017 Jul 14.

PMID:
28715695
33.

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.

Jusakul A, Cutcutache I, Yong CH, Lim JQ, Huang MN, Padmanabhan N, Nellore V, Kongpetch S, Ng AWT, Ng LM, Choo SP, Myint SS, Thanan R, Nagarajan S, Lim WK, Ng CCY, Boot A, Liu M, Ong CK, Rajasegaran V, Lie S, Lim AST, Lim TH, Tan J, Loh JL, McPherson JR, Khuntikeo N, Bhudhisawasdi V, Yongvanit P, Wongkham S, Totoki Y, Nakamura H, Arai Y, Yamasaki S, Chow PK, Chung AYF, Ooi LLPJ, Lim KH, Dima S, Duda DG, Popescu I, Broet P, Hsieh SY, Yu MC, Scarpa A, Lai J, Luo DX, Carvalho AL, Vettore AL, Rhee H, Park YN, Alexandrov LB, Gordân R, Rozen SG, Shibata T, Pairojkul C, Teh BT, Tan P.

Cancer Discov. 2017 Oct;7(10):1116-1135. doi: 10.1158/2159-8290.CD-17-0368. Epub 2017 Jun 30.

34.

Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma.

Rhee H, Ko JE, Chung T, Jee BA, Kwon SM, Nahm JH, Seok JY, Yoo JE, Choi JS, Thorgeirsson SS, Andersen JB, Lee HS, Woo HG, Park YN.

Liver Int. 2018 Jan;38(1):113-124. doi: 10.1111/liv.13492. Epub 2017 Jul 10.

PMID:
28608943
35.

Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection.

Lee HW, Choi GH, Kim DY, Park YN, Kim KS, Choi JS, Ahn SH, Han KH.

Oncology. 2017;93(4):224-232. doi: 10.1159/000477173. Epub 2017 Jun 2.

PMID:
28571030
36.

The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma.

Park ER, Kim SB, Lee JS, Kim YH, Lee DH, Cho EH, Park SH, Han CJ, Kim BY, Choi DW, Yoo YD, Yu A, Lee JW, Jang JJ, Park YN, Suh KS, Lee KH.

Cancer Med. 2017 Apr;6(4):749-760. doi: 10.1002/cam4.1042. Epub 2017 Mar 23.

37.

Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma.

Kim YJ, Rhee H, Yoo JE, Alves VAF, Kim GJ, Kim HM, Herman P, Chagas A, Kim H, Park YN.

Histopathology. 2017 Aug;71(2):217-226. doi: 10.1111/his.13219. Epub 2017 May 22.

PMID:
28326574
38.

Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma.

Lee JS, Yoo JE, Kim H, Rhee H, Koh MJ, Nahm JH, Choi JS, Lee KH, Park YN.

PLoS One. 2017 Mar 8;12(3):e0171922. doi: 10.1371/journal.pone.0171922. eCollection 2017.

39.

Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis.

Kim JK, Kim SJ, Kim Y, Chung YE, Park YN, Kim HO, Kim JS, Park MS, Sakaida I, Kim DY, Lee JI, Ahn SH, Lee KS, Han KH.

Cell Transplant. 2017 Jun 9;26(6):1059-1066. doi: 10.3727/096368917X694778. Epub 2017 Jan 24.

40.

Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis.

Yoo JE, Kim YJ, Rhee H, Kim H, Ahn EY, Choi JS, Roncalli M, Park YN.

PLoS One. 2017 Jan 23;12(1):e0170465. doi: 10.1371/journal.pone.0170465. eCollection 2017.

41.

Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.

Kim YJ, Jeon Y, Kim T, Lim WC, Ham J, Park YN, Kim TJ, Ko H.

Bioorg Med Chem Lett. 2017 Feb 15;27(4):1081-1088. doi: 10.1016/j.bmcl.2016.12.042. Epub 2016 Dec 20.

PMID:
28110870
42.

CYP1A2 is a predictor of HCC recurrence in HCV-related chronic liver disease: A retrospective multicentric validation study.

Sciarra A, Pintea B, Nahm JH, Donadon M, Morenghi E, Maggioni M, Blanc JF, Torzilli G, Yeh M, Bioulac-Sage P, Park YN, Roncalli M, Di Tommaso L.

Dig Liver Dis. 2017 Apr;49(4):434-439. doi: 10.1016/j.dld.2016.12.002. Epub 2016 Dec 16.

PMID:
28040498
43.

Feasibility of Preoperative FDG PET/CT Total Hepatic Glycolysis in the Remnant Liver for the Prediction of Postoperative Liver Function.

Cho A, Chung YE, Choi JS, Kim KS, Choi GH, Park YN, Kim MJ.

AJR Am J Roentgenol. 2017 Mar;208(3):624-631. doi: 10.2214/AJR.16.16450. Epub 2016 Dec 27.

PMID:
28026972
44.

Transarterial Therapies for Hepatocellular Carcinoma.

Lanza E, Donadon M, Poretti D, Pedicini V, Tramarin M, Roncalli M, Rhee H, Park YN, Torzilli G.

Liver Cancer. 2016 Nov;6(1):27-33. Epub 2016 Nov 29. Review.

45.

Spontaneous rupture of hepatic metastasis from a thymoma: A case report.

Kim HJ, Park YE, Ki MS, Lee SJ, Beom SH, Han DH, Park YN, Park JY.

World J Gastroenterol. 2016 Nov 28;22(44):9860-9864.

46.

Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus.

Heo JY, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Park YN, Ahn SS, Han KH, Kim HS.

Medicine (Baltimore). 2016 Apr;95(14):e3328.

47.

Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.

An C, Rhee H, Han K, Choi JY, Park YN, Park MS, Kim MJ, Park S.

Eur Radiol. 2017 Jun;27(6):2610-2618. doi: 10.1007/s00330-016-4634-6. Epub 2016 Oct 21.

PMID:
27770230
48.

Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy.

Han DH, Joo DJ, Kim MS, Choi GH, Choi JS, Park YN, Seong J, Han KH, Kim SI.

Yonsei Med J. 2016 Sep;57(5):1276-81. doi: 10.3349/ymj.2016.57.5.1276.

49.

Erratum: Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response.

Lee HW, Chon YE, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Jung KS, Park YN, Han KH.

Gut Liver. 2016 Jul 15;10(4):653-655. doi: 10.5009/gnl150211. No abstract available.

50.

Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization.

Rhee H, Nahm JH, Kim H, Choi GH, Yoo JE, Lee HS, Koh MJ, Park YN.

Mod Pathol. 2016 Sep;29(9):1038-49. doi: 10.1038/modpathol.2016.111. Epub 2016 Jun 17.

Supplemental Content

Support Center